ArticleTranslational lung cancer research2023

Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC).

Dae-Ho Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.